CEO Corner articles are written by presidents or CEOs of biopharmaceutical or medical device companies that create a drug or device. These articles discuss global industry trends, experiences, and challenges that biopharma CEOs and presidents can relate to and should be aware of. To submit a CEO Corner article, please follow these guidelines.
Skills I Learned That Have Helped Me As A Public Pharma CEO
While I learned a great deal about the industry in the latter part of my career, as a leader, my foundation was molded by the valuable lessons learned in two very different spaces — the U.S. Army Reserve and nursing.
Creating A Culture of Innovation In Any Size Organization
A company’s size and culture play a large role in how it defines and executes innovation.
What The Sale Of Agios’ Oncology Pipeline Taught Me
Anytime a company undergoes organizational change — even if it’s a good change — the road there is not necessarily an easy one. I’d like to share a few things that might make it — or any major decision — easier for you
How European Biopharmas Can Benefit From Establishing A U.S. Presence
The maturity and scale of the biotech industry in the U.S. can offer several competitive advantages, making expansion into the U.S. well worth considering for leaders of biopharma companies formed in other countries, such as across Europe.
Against All Odds: Advancing From R&D To Phase 3
There is nothing more rewarding than knowing that we can help save a life and give hope to patients and their friends and families. Because lives are at stake, there must be more regulations and processes to ensure safety and efficacy.
Capitalization, Coaching, And Clarity Are Keys To Success
Throughout my career, I have employed the following guiding principles to advance treatment options for patients: capitalization is king, hire the right people, and be decisive and humble.
From Academia to Industry – How Biopharma Entrepreneurship Became A Calling
While I knew that I wanted to dedicate my life to developing gene therapies to cure human diseases, I could not have predicted that I would leave academia to become an entrepreneur.
A Black CEO’s Advice To The Next Generation
As one of the few African American CEOs in corporate America, I am in a unique position to share my experience with the next generation of leaders as we continue to face major challenges around inequity, intolerance, and community cohesion.
Coworking Lab Spaces Help Life Science Startups Succeed
While business incubators are not uncommon, facilities like these provide laboratory equipment and staff to manage safety, training, and other lab operations for entrepreneurs to reduce their initial investment expenses.
What I Learned As A Teacher That Made Me A Better Leader
Before I started my career in the pharmaceutical industry, I was a chemistry and biology teacher. While my days in the classroom now feel like a lifetime ago, a day rarely passes that I don't draw upon the range of skills I honed back then.
BEYOND THE PRINTED PAGE
A Tough Business Lesson To Learn10/25/2021
Lisa Conte, founder and CEO of Jaguar Health, shares her wisdom from corporate collaboration lessons learned the hard way.
CEO Advice From A 30-Year Pharma Veteran10/18/2021
Lisa Conte, founder of Jaguar Health, shares her thoughts on becoming a biopharmaceutical company CEO, and the approach taken to create the proper corporate culture.
Don’t Think Executing A Biopharma SPAC Is Easy9/20/2021
Michael Byrnes, CFO at eFFECTOR Therapeutics, provides a prequel to an upcoming two-part article in Life Science Leader, with some specific recommendations for executive teams on SPACs.
LIFE SCIENCE LEADER BLOGS
Three biopharmaceutical executives discuss plans around their company getting back to in-office operations.
Recent events of female athletes expressing the need to focus on their mental health seems to point toward mental wellness being one of the next big things, along with women leaders being willing to "rewrite the rules."